The PE Ratio as of November 2024 (TTM) for ContraFect Corporation (CFRX) is -0.02

According to ContraFect Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -80.36% compared to the average of -0.10 of the last 4 quarters.

ContraFect Corporation (CFRX) Historical PE Ratio (quarterly & annually)

How has CFRX PE Ratio performed in the past?

The mean historical PE Ratio of ContraFect Corporation over the last ten years is -1.07. The current -0.02 PE Ratio has changed 86.96% with respect to the historical average. Over the past ten years (40 quarters), CFRX's PE Ratio was at its highest in in the December 2016 quarter at 30.66. The PE Ratio was at its lowest in in the September 2017 quarter at -11.44.

ContraFect Corporation (CFRX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of ContraFect Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ContraFect Corporation (CFRX) Average PE Ratio

How has CFRX PE Ratio performed in the past?

The current PE Ratio of ContraFect Corporation (CFRX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

ContraFect Corporation (CFRX) PE Ratio vs. Peers

How is CFRX’s PE Ratio compared to its peers?

ContraFect Corporation’s PE Ratio is less than Palisade Bio, Inc. (0), greater than Allarity Therapeutics, Inc. (-0.26), greater than CNS Pharmaceuticals, Inc. (-0.10), greater than Windtree Therapeutics, Inc. (-0.16), greater than Quoin Pharmaceuticals, Ltd. (-0.03), greater than Revelation Biosciences, Inc. (-0.33), greater than Virax Biolabs Group Limited (-0.13), greater than Unicycive Therapeutics, Inc. (-0.67), greater than NeuroBo Pharmaceuticals, Inc. (-1.63), greater than Hillstream BioPharma, Inc. (-0.87), greater than First Wave BioPharma, Inc. (-0.99), greater than Dermata Therapeutics, Inc. (-0.85), greater than Panbela Therapeutics, Inc. (-0.16), greater than null (-0.06),

Build a custom stock screener for ContraFect Corporation (CFRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ContraFect Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ContraFect Corporation (CFRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ContraFect Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.